Myelocortical multiple sclerosis appears to be due to degeneration of neurons.
Multiple sclerosis (MS) is an autoimmune demyelinating disease characterized by white matter plaques with variable loss of axons. Investigators evaluated the pathologic characteristics of patients who appeared not to have demyelinating white matter lesions at autopsy.
Of 100 patients with MS who underwent autopsy, 12 had no visible white matter lesions on gross inspection of 1 cm slices; these patients were classified as having myelocortical MS (mMS). The mMS cases were matched with 12 individuals with typical MS (tMS), based on visible white matter lesions at autopsy.
The most common clinical phenotype in mMS was secondary progressive MS, but relapsing remitting and primary progressive MS were also represented. Cerebral white matter lesion a…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)